Cardinal's Growth Momentum Looks Strong From Prescription Trends, Specialty Investments, and GLP-1s

Cardinal Health Q3 FY26 slides: EPS beats, guidance raised amid tariff headwinds

Is Cardinal Health (CAH) Overvalued After Q3 FY26 Earnings? Adj.

Cardinal Health, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:CAH) 2026-04-30

Cardinal Health (CAH) Reports Q3 Earnings, Raises FY26 EPS Guida

Cardinal Health (CAH) Stock Rises on Upgraded Full-Year Earnings Forecast Despite Revenue Shortfall

Cardinal Health (CAH) Reports Q3 Earnings, Raises FY26 EPS Guida

Cardinal Health Releases Q3 2026 Financial Results

Cardinal Health Posts Strong Q3 2026 Non-GAAP Results

Cardinal Health Inc (NYSE:CAH) Surges on Q3 Earnings Beat and Raised Guidance

Cardinal Health (NYSE:CAH) Misses Q1 CY2026 Sales Expectations

Earnings Flash (CAH) Cardinal Health, Inc. Reports Q3 Revenue $60.94B, vs. FactSet Est of $62.10B

Earnings Flash (CAH) Cardinal Health, Inc. Posts Q3 Adjusted EPS $3.17 per Share, vs. FactSet Est of $2.79

Cardinal: Fiscal Q3 Earnings Snapshot

Cardinal: Fiscal Q3 Earnings Snapshot

Earnings Flash (CAH) Cardinal Health, Inc. Posts Q3 Adjusted EPS $3.17 per Share, Vs. FactSet Est of $2.79

Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook – Company Announcement